Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)
Status:
Withdrawn
Trial end date:
2018-10-09
Target enrollment:
Participant gender:
Summary
This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced
nephropathy. All of the patients will receive endovenous normal saline to prevent
nephropathy, half of the patients will receive remote ischemic preconditioning while the
other half will not.